Thelansis

REM Sleep Behavior Disorder (RBD) Market Outlook Thelansis’s “REM Sleep Behavior Disorder (RBD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential REM Sleep Behavior Disorder (RBD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest ...

  REM Sleep Behavior Disorder (RBD) Market Outlook Thelansis’s “REM Sleep Behavior Disorder (RBD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential REM Sleep Behavior Disorder (RBD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). REM Sleep Behavior Disorder (RBD) Overview Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by the absence of muscle atonia during REM sleep, known as REM sleep without atonia (RSWA), and the occurrence of abnormal behaviors during REM sleep, often resembling actions from dreams that can result in physical harm. RBD can be classified as either idiopathic RBD or symptom...

  Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by the absence of muscle atonia during REM sleep, known as REM sleep without atonia (RSWA), and the occurrence of abnormal behaviors during REM sleep, often resembling actions from dreams that can result in physical harm. RBD can be classified as either idiopathic RBD or symptomatic RBD, the latter being associated with the use of antidepressant medication or neurological disorders, particularly α-synucleinopathies such as Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and narcolepsy type 1. The underlying cause of RBD is the failure to inhibit spinal motor neurons during REM sleep. A significant correlation has been established between RBD and the subsequent development of neurodegenerative disorders. Neurodegenerative diseases characterized by alpha-synuclein-positive intracellular inclusions, including parkinsonism, Lewy body dementia, and multiple system atrophy, a...